ENLV Long Call Strategy
ENLV (Enlivex Therapeutics Ltd.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
ENLV (Enlivex Therapeutics Ltd.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $31.0M, a trailing P/E of 0.00, a beta of 1.47 versus the broader market, a 52-week range of 1.72-31.5, average daily share volume of 110K, a public-listing history dating back to 2014, approximately 34 full-time employees. These structural characteristics shape how ENLV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.47 indicates ENLV has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 0.00 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a long call on ENLV?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
ENLV snapshot
As of August 14, 2026, spot at $1.75, ATM IV 298.90%, IV rank 60.22%, expected move 85.69%. The long call on ENLV below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long call structure on ENLV specifically: ENLV IV at 298.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 85.69% (roughly $1.50 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ENLV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ENLV should anchor to the underlying notional of $1.75 per share and to the trader's directional view on ENLV stock.
ENLV long call setup
The ENLV long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ENLV at $1.75 on that close, the first option leg uses a $1.75 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ENLV chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ENLV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.75 | N/A |
ENLV long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
ENLV long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on ENLV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on ENLV
Long calls on ENLV express a bullish thesis with defined risk; traders use them ahead of ENLV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
ENLV thesis for this long call
The market-implied 1-standard-deviation range for ENLV extends from approximately $0.25 on the downside to $3.25 on the upside. A ENLV long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ENLV IV rank near 60.22% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ENLV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ENLV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ENLV-specific events.
ENLV long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ENLV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ENLV alongside the broader basket even when ENLV-specific fundamentals are unchanged. Long-premium structures like a long call on ENLV are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ENLV chain quotes before placing a trade.
Frequently asked questions
- What is a long call on ENLV?
- A long call on ENLV is the long call strategy applied to ENLV (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ENLV stock at $1.75 on the most recent close, the strikes shown on this page are snapped to the nearest listed ENLV chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ENLV long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ENLV long call priced from the end-of-day chain at a 30-day expiry (ATM IV 298.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ENLV long call?
- The breakeven for the ENLV long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ENLV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 85.69%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on ENLV?
- Long calls on ENLV express a bullish thesis with defined risk; traders use them ahead of ENLV catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current ENLV implied volatility affect this long call?
- ENLV ATM IV is at 298.90% with IV rank near 60.22%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.